Related references
Note: Only part of the references are listed.Gαi1 and Gαi3mediate VEGF-induced VEGFR2 endocytosis, signaling and angiogenesis
Jian Sun et al.
THERANOSTICS (2018)
Competitive tuning: Competition's role in setting the frequency-dependence of Ca2+-dependent proteins
Daniel R. Romano et al.
PLOS COMPUTATIONAL BIOLOGY (2017)
Predictive model identifies strategies to enhance TSP1-mediated apoptosis signaling
Qianhui Wu et al.
CELL COMMUNICATION AND SIGNALING (2017)
VEGFR1 promotes cell migration and proliferation through PLC gamma and PI3K pathways
Jared C. Weddell et al.
NPJ SYSTEMS BIOLOGY AND APPLICATIONS (2017)
A Computational Model for Investigating Tumor Apoptosis Induced by Mesenchymal Stem Cell-Derived Secretome
Melisa Hendrata et al.
COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE (2016)
Vegfa signals through ERK to promote angiogenesis, but not artery differentiation
Masahiro Shin et al.
DEVELOPMENT (2016)
ERK activation in endothelial cells is a novel marker during neovasculogenesis
Ayumi Nagasawa-Masuda et al.
GENES TO CELLS (2016)
VEGF induces signalling and angiogenesis by directing VEGFR2 internalisation through macropinocytosis
Dimitris Basagiannis et al.
JOURNAL OF CELL SCIENCE (2016)
Effects of combinations of BMP-2 with FGF-2 and/or VEGF on HUVECs angiogenesis in vitro and CAM angiogenesis in vivo
Yan Bai et al.
CELL AND TISSUE RESEARCH (2014)
Deciphering the mechanism behind Fibroblast Growth Factor (FGF) induced biphasic signal-response profiles
Jitendra Kanodia et al.
CELL COMMUNICATION AND SIGNALING (2014)
Quantitative fluorescent profiling of VEGFRs reveals tumor cell and endothelial cell heterogeneity in breast cancer xenografts
Princess I. Imoukhuede et al.
CANCER MEDICINE (2014)
Computational model of VEGFR2 pathway to ERK activation and modulation through receptor trafficking
Wan Hua Tan et al.
CELLULAR SIGNALLING (2013)
A CONTINUOUS MODEL OF ANGIOGENESIS: INITIATION, EXTENSION, AND MATURATION OF NEW BLOOD VESSELS MODULATED BY VASCULAR ENDOTHELIAL GROWTH FACTOR, ANGIOPOIETINS, PLATELET-DERIVED GROWTH FACTOR-B, AND PERICYTES
Xiaoming Zheng et al.
DISCRETE AND CONTINUOUS DYNAMICAL SYSTEMS-SERIES B (2013)
Essential Role for Endocytosis in the Growth Factor-stimulated Activation of ERK1/2 in Endothelial Cells
Morgane Gourlaouen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Computational Model of Gab1/2-Dependent VEGFR2 Pathway to Akt Activation
Wan Hua Tan et al.
PLOS ONE (2013)
The US FDAs withdrawal of the breast cancer indication for Avastin (bevacizumab)
Larry D. Sasich et al.
SAUDI PHARMACEUTICAL JOURNAL (2012)
FGF-dependent regulation of VEGF receptor 2 expression in mice
Masahiro Murakami et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Effect of VEGF and VEGF Trap on vascular endothelial cell signaling in tumors
Wiem Lassoued et al.
CANCER BIOLOGY & THERAPY (2010)
Increase of Plasma VEGF after Intravenous Administration of Bevacizumab Is Predicted by a Pharmacokinetic Model
Marianne O. Stefanini et al.
CANCER RESEARCH (2010)
Identification of Optimal Drug Combinations Targeting Cellular Networks: Integrating Phospho-Proteomics and Computational Network Analysis
Sergio Iadevaia et al.
CANCER RESEARCH (2010)
VEGF-dependent tumor angiogenesis requires inverse and reciprocal regulation of VEGFR1 and VEGFR2
Z. Zhang et al.
CELL DEATH AND DIFFERENTIATION (2010)
Ligand Depletion in vivo Modulates the Dynamic Range and Cooperativity of Signal Transduction
Stuart J. Edelstein et al.
PLOS ONE (2010)
Ligand-Stimulated VEGFR2 Signaling is Regulated by Co-Ordinated Trafficking and Proteolysis
Alexander F. Bruns et al.
TRAFFIC (2010)
Endothelial Cell Capture of Heparin-Binding Growth Factors under Flow
Bing Zhao et al.
PLOS COMPUTATIONAL BIOLOGY (2010)
The Role of Fibroblast Growth Factors in Tumor Growth
M. Korc et al.
CURRENT CANCER DRUG TARGETS (2009)
New Role for the Protein Tyrosine Phosphatase DEP-1 in Akt Activation and Endothelial Cell Survival
Catherine Chabot et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Vascularization Strategies for Tissue Engineering
Michael Lovett et al.
TISSUE ENGINEERING PART B-REVIEWS (2009)
Activation of multiple signaling pathways is critical for fibroblast growth factor 2-and vascular endothelial growth factor-stimulated ovine fetoplacental endothelial cell proliferation
Jing Zheng et al.
BIOLOGY OF REPRODUCTION (2008)
Calmodulin Mediates Differential Sensitivity of CaMKII and Calcineurin to Local Ca2+ in Cardiac Myocytes
Jeffrey J. Saucerman et al.
BIOPHYSICAL JOURNAL (2008)
A methodology for performing global uncertainty and sensitivity analysis in systems biology
Simeone Marino et al.
JOURNAL OF THEORETICAL BIOLOGY (2008)
Dose response of angiogenesis to basic fibroblast growth factor in rat corneal pocket assay: II. Numerical simulations
Sheng Tong et al.
MICROVASCULAR RESEARCH (2008)
ERK implication in cell cycle regulation
Jean-Claude Chambard et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2007)
Targeting neuropilin-1 to inhibit VEGF signaling in cancer: Comparison of therapeutic approaches
Feilim Mac Gabhann et al.
PLOS COMPUTATIONAL BIOLOGY (2006)
Phosphorylation of Tyr1214 within VEGFR-2 triggers the recruitment of Nck and activation of Fyn leading to SAPK2/p38 activation and endothelial cell migration in response to VEGF
Laurent Lamalice et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Fibroblast growth factor 2 induced proliferation in osteoblasts and bone marrow stromal cells: A whole cell model
Melissa A. Dupree et al.
BIOPHYSICAL JOURNAL (2006)
Vascular endothelial cadherin controls VEGFR-2 internalization and signaling from intracellular compartments
Maria Grazia Lampugnani et al.
JOURNAL OF CELL BIOLOGY (2006)
VEGF receptor signalling - in control of vascular function
AK Olsson et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
ERK-MAPK signaling opposes Rho-kinase to promote endothelial cell survival and sprouting during angiogenesis
G Mavria et al.
CANCER CELL (2006)
VEGF-A and FGF-2 synergistically promote neoangiogenesis through enhancement of endogenous PDGF-B-PDGFRβ signaling
MR Kano et al.
JOURNAL OF CELL SCIENCE (2005)
Intracoronary administration of FGF-2: a computational model of myocardial deposition and retention
RJ Filion et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
A reaction-diffusion model of basic fibroblast growth factor interactions with cell surface receptors
RJ Filion et al.
ANNALS OF BIOMEDICAL ENGINEERING (2004)
Kinetic model for FGF, FGFR, and proteoglycan signal transduction complex assembly
OA Ibrahimi et al.
BIOCHEMISTRY (2004)
Dose-dependent response of FGF-2 for lymphangiogenesis
LK Chang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Vascular endothelial growth factor in ischemia for vascular angiogenesis
TD Henry et al.
CIRCULATION (2003)
Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2 - Double-blind, randomized, controlled clinical trial
M Simons et al.
CIRCULATION (2002)
Mechanisms of fibroblast growth factor 2 intracellular processing: A kinetic analysis of the role of heparan sulfate proteoglycans
GV Sperinde et al.
BIOCHEMISTRY (2000)
Lysophosphatidylcholine inhibits endothelial cell migration and proliferation via inhibition of the extracellular signal-regulated kinase pathway
Y Rikitake et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
Effect of vascular endothelial growth factor on cultured endothelial cell monolayer transport properties
YS Chang et al.
MICROVASCULAR RESEARCH (2000)
Share Paper
